4//SEC Filing
Rutherford Colin 4
Accession 0001209191-18-019694
CIK 0001618835other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:15 PM ET
Size
8.3 KB
Accession
0001209191-18-019694
Insider Transaction Report
Form 4
Rutherford Colin
Director
Transactions
- Award
Stock option (right to buy)
2018-03-12+15,000→ 15,000 totalExercise: $7.29Exp: 2028-03-12→ Common Stock (15,000 underlying) - Award
Stock option (right to buy)
2018-03-12+24,691→ 24,691 totalExercise: $7.29Exp: 2028-03-12→ Common Stock (24,691 underlying)
Footnotes (2)
- [F1]Mr. Rutherford acquired a vested interest in one hundred percent (100%) of the shares of common stock exercisable pursuant to the option effective as of March 12, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from March 12, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726264
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:15 PM ET
- Size
- 8.3 KB